Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 sept. 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference

SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced...
10 août 2015 16h01 HE | Source: Zogenix, Inc.

Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
05 août 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
03 août 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix to Release Second Quarter 2015 Financial Results and Host Conference Call & Webcast on August 10

SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
30 juil. 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix Prices Public Offering of Common Stock

SAN DIEGO, July 30, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
28 juil. 2015 16h38 HE | Source: Zogenix, Inc.

Zogenix Announces Proposed Public Offering of 3,800,000 Shares of Common Stock

SAN DIEGO, July 28, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
07 juil. 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix to Host Key Opinion Leader Meeting Tuesday, July 14, in New York City

SAN DIEGO, July 7, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
06 juil. 2015 08h30 HE | Source: Zogenix, Inc.

Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development

SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...
06 juil. 2015 08h00 HE | Source: Zogenix, Inc.

Zogenix to Participate in Cantor Fitzgerald Healthcare Conference

SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS)...
18 juin 2015 16h18 HE | Source: Zogenix, Inc.

Zogenix Announces Shareholders and Board of Directors Approve Reverse Stock Split

SAN DIEGO, June 18, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...

Page précédente

Page suivante